Hypermetabolism in ALS: Correlations with clinical and paraclinical parameters

Neurodegenerative Diseases

Volumn 2, Issue 3-4, 2006, Pages 202-207

  Desport, Jean Claude ^a,b   Torny, Frédéric ^a   Lacoste, Mathieu ^a   Preux, Pierre Marie ^b   Couratier, Philippe ^a,b  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF LIMOGES   (France)

Author keywords

Amyotrophic lateral sclerosis; Hypermetabolism; Phase angle; Survival

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BODY FAT; BODY MASS; CALCULATION; CALORIMETRY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH; DISEASE COURSE; ENERGY EXPENDITURE; FEMALE; FUNCTIONAL ASSESSMENT; GENETIC LINKAGE; HUMAN; HYPERMETABOLISM; IMPEDANCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUTRITIONAL ASSESSMENT; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; REST; SEX; SKELETAL MUSCLE; SURVIVAL; VITAL CAPACITY;

AGE FACTORS; AMYOTROPHIC LATERAL SCLEROSIS; BASAL METABOLISM; BODY COMPOSITION; CALORIMETRY, INDIRECT; ENERGY METABOLISM; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SEX FACTORS;

EID: 33744816556     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000089626     Document Type: Article

References (36)

1. Leigh PN, Ray-Chaudhuri K: Motor neurone disease. J Neurol Neurosurg Psychiatry 1994;57:886-896.
2. Mitsumoto H, Chad DA, Pioro EP: Course and prognosis; in Mitsumoto H, Chad DA, Pioro EP (eds): Amyotrophic Lateral Sclerosis. Philadelphia, Davis, 1998, pp 151-163.
3. Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P: Nutritional status is a prognostic factor for survival in ALS patients. Neurology 1999;53:1059-1063.
4. Borasio GD, Voltz R: Palliative care in amyotrophic lateral sclerosis. J Neurol 1997;244(suppl 4):S11-S17.
5. McDonald ER, Wiedenfeld SA, Hillel A, Carpenter CL, Walter RA: Survival in amyotrophic lateral sclerosis. The role of psychological factors. Arch Neurol 1994;51:17-23.
6. Kasarskis EJ, Berryman S, Vanderleest JG, Schneider AR, McClain CJ: Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr 1996;63:130-137.
7. Desport JC, Preux PM, Truong CT, Courat L, Vallat JM, Couratier P: Nutritional assessment and survival in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:91-96.
8. Slowie LA, Paige MS, Antel JP: Nutritional considerations in the management of patients with amyotrophic lateral sclerosis. J Am Diet Assoc 1983;83:44-47.
9. Desport JC, Preux PM, Truong CT, Vallat JM, Couratier P: Factors correlated with hypermetabolism in amyotrophic lateral sclerosis. Am J Clin Nutr 2001;74:328-334.
10. Lew EA, Garfinkel L: Variations in mortality by weight among 750,000 men and women. J Chronic Dis 1979;32:563-576.
11. Baumgartner RN, Chumlea WC, Roche AF: Bioelectric impedance phase angle and body composition. Am J Clin Nutr 1988;48:16-23.
12. Ferranini E: The theoretical bases of indirect calorimetry: a review. Metabolism 1988;37:287-301.
13. Simonson DC, DeFronzo RA: Indirect calorimetry: methodological and interpretative problems. Am J Physiol 1990;258:E399-E412.
14. Harris JA, Benedict FG: A Biometric Study of Basal Metabolism in Man. Washington, Carnegie Institute of Washington, 1919, publ No 279.
15. Aid to the Investigation of Peripheral Nerve Injuries; in Medical Research Council. War Memorandum, ed 2 rev. London, HMSO, 1943, pp 11-46.
16. ALS CNTF Treatment Study (ACTS) Phase I-II Study Group: The amyotrophic lateral sclerosis functional rating scale: assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 1996;53:141-147.
17. Bensimon G, Lacomblez L, Meininger V, and ALS/Riluzole Study Group: A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994;330:585-591.
18. Kanda F, Fujii Y, Takahashi K, Fujita T: Dual-energy X-ray absorptiometry in neuromuscular diseases. Muscle Nerve 1994;17:431-435.
19. Nau KL, Bromberg MB, Forshew DA, Katch VL: Individuals with amyotrophic lateral sclerosis are in caloric balance despite losses in mass. J Neurol Sci 1995;129(suppl):47-49.
20. Tandan R, Krusinski PB, Hiser JR, Howard DB, Barsotti S, Thornton C, Griggs RC: The validity and sensitivity of dual energy X-ray absorptiometry in estimating lean body mass in amyotrophic lateral sclerosis; in Proc 9th International Symposium on ALS/MND, Munich, Nov 16-18, 1998. Munich, ALS Association, 1998, p 48.
21. Shimizu T, Hayashi H, Tanabe H: Energy metabolism of ALS patients under mechanical ventilation and tube feeding. Clin Neurol 1991;31:255-259.
22. Poehlman ET: Regulation of energy expenditure in aging humans. J Am Geriatr Soc 1993;41:552-559.
23. Dupuis L, Oudart H, Rene F, Gonzalez de Aguilar JL, Loeffler JP: Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci USA 2004;101:11159-11164.
24. Bergeron C: Oxidative stress - its role in the pathogenesis of amyotrophic lateral sclerosis. J Neurol Sci 1995;129:81-84.
25. Heales SJR, Bolanos JP, Stewart VC, Brookes PS, Land JM, Clark JB: Nitric oxide, mitochondria and neurological disease. Biochim Biophys Acta 1999;1410:215-228.
26. McGeer PL, McGeer EG: The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 1995;21:195-218.
27. Estevez AG, Crow JP, Sampson JB, Reiter C, Zhuang Y, Richardson GJ, Tarpey MM, Barbeito L, Beckman JS: Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science 1999;286:2498-2500.
28. Torreilles F, Salman-Tabcheh S, Guerin M, Torreilles J: Neurodegenerative disorders: the role of peroxynitrite. Brain Res Brain Res Rev 1999;30:153-163.
29. Ciriolo MR, De Martino A, Lafavia E, Rossi L, Carri MT, Rotilio G. Cu, Zn-superoxide dismutase-dependent apoptosis induced by nitric oxide in neuronal cells. J Biol Chem 2000;275:5065-5072.
30. Murphy M: Slip and leak in mitochondrial oxidative phosphorylation. Biochim Biophys Acta 1989;977:123-141.
31. Beal MF: Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1998;1366:211-223.
32. Markus HS, Cox M, Tomkins AM: Raised resting energy expenditure in Parkinson's disease and its relationship to muscle rigidity. Clin Sci 1992;83:199-204.
33. Toth MJ, Fishman PS, Poehlman ET: Free-living daily energy expenditure in patients with Parkinson's disease. Neurology 1997;48:88-91.
34. Poehlman ET, Dvorak RV: Energy expenditure, energy intake, and weight loss in Alzheimer disease. Am J Clin Nutr 2000;71(suppl):S650-S655.
35. De Carvalho M, Nogueira A, Pinto A, Miguens J, Sales Luis ML: Reflex sympathetic dystrophy associated with amyotrophic lateral sclerosis. J Neurol Sci 1999;169:80-83.
36. Dettmers C, Fatepour D, Faust H, Jerusalem F: Sympathetic skin response abnormalities in amyotrophic lateral sclerosis. Muscle Nerve 1993;16:930-934.